G-CSF (Granulocyte Colony-Stimulating Factor) is a hematopoietic growth factor that stimulates the production, maturation and release of neutrophils from the bone marrow. Recombinant G-CSF products are widely used in supportive cancer care to reduce the duration and severity of chemotherapy-induced neutropenia and to support neutrophil recovery.
The most widely recognized recombinant human G-CSF molecule is filgrastim, a recombinant form of human granulocyte colony-stimulating factor. G-CSF products are also used in specific settings such as peripheral blood stem-cell mobilization.
G-CSF is a recombinant protein rather than a conventional small-molecule API. It is produced using biotechnology-based recombinant DNA processes and requires specialized manufacturing and analytical characterization.
G-CSF binds to the granulocyte colony-stimulating factor receptor (G-CSFR) on hematopoietic cells. Receptor activation stimulates intracellular signaling pathways that promote proliferation, differentiation and survival of neutrophil precursor cells, resulting in increased circulating neutrophil counts.
G-CSF is used in pharmaceutical products for applications including:
Recombinant human G-CSF is structurally and functionally related to naturally occurring human G-CSF. Filgrastim is a recombinant human G-CSF product consisting of a 175-amino-acid protein and is commonly used as the reference molecule for recombinant G-CSF products.
Because G-CSF is a recombinant protein, quality assessment requires protein-specific analytical methods. Testing may include identity by peptide mapping or mass spectrometry, purity by chromatographic methods, protein concentration, biological activity/potency, aggregation, host-cell protein, host-cell DNA, residual process-related impurities and sterility/endotoxin testing for finished sterile products.
G-CSF recombinant protein products generally require controlled refrigerated storage. The exact temperature, light-protection requirements, allowable excursions and handling conditions depend on the specific G-CSF product and validated stability data.
G-CSF is an important recombinant therapeutic protein in hematology, oncology and regenerative medicine research. Its ability to stimulate granulopoiesis makes it an important biological agent for managing neutrophil depletion and for mobilizing hematopoietic stem/progenitor cells.
G-CSF is a recombinant hematopoietic growth factor that promotes neutrophil production and maturation. It is particularly important in oncology supportive care and stem-cell mobilization. Unlike small-molecule APIs, G-CSF requires protein-specific characterization and biological potency testing.
| Parameter | Specification |
|---|---|
| Appearance | White to off-white crystalline powder |
| Identification | IR & HPLC compliant |
| Assay (HPLC) | 98.0% – 102.0% |
| Loss on Drying | NMT 1.0% |
| Residue on Ignition | NMT 0.5% |
| Heavy Metals | NMT 10 ppm |
| pH (1% Solution) | 2.0 – 4.0 |
| Individual Impurity | NMT 0.5% |
| Total Impurities | NMT 1.0% |
| Water Content | NMT 1.0% |